NK

Nimishaben Kantilal Patel

Active Director Director DIN 07590368
DIN 07590368 First appointment Sep 2016 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2016
Shareholding value •••• Premium profile

About Nimishaben Kantilal Patel

Data last updated:

Nimishaben Kantilal Patel is a Director at Aylen Pharmaceutical Private Limited (since 2016). The company operates in Pharma. Aylen Pharmaceutical Private Limited reported revenue of ₹1.05 Cr (FY 2024).

DIN 07590368
Primary Designation Director
Industry Pharma
First Appointment 26 Sep 2016
Oldest Company Age 10 yrs
Largest company Aylen Pharmaceutical Private Limited · ₹1.05 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aylen Pharmaceutical Private Limited U74999GJ2016PTC093879
Director26 Sep 20162016₹1.05 Cr (FY 2024)Active

Board colleagues of Nimishaben Kantilal Patel

Directorship timeline

Open interactive timeline →
Aylen Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Nimishaben Kantilal Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nimishaben Kantilal Patel

Nimishaben Kantilal Patel currently holds 1 directorship: Aylen Pharmaceutical Private Limited (Director, since 26 Sep 2016, revenue ₹1.05 Cr (FY 2024)).

Nimishaben Kantilal Patel was first appointed on 26 Sep 2016 as Director at Aylen Pharmaceutical Private Limited.

The current boards of Nimishaben Kantilal Patel's companies include Pragneshkumar Kantilal Patel (Aylen Pharmaceutical Private Limited), Purviben Ashishbhai Rajyaguru (Aylen Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available